Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00152386
Recruitment Status : Completed
First Posted : September 9, 2005
Last Update Posted : December 1, 2020
Sponsor:
Information provided by:
UCB Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2006
Actual Study Completion Date : October 2006
Publications of Results:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):